Clindamycin Phosphate

ANDA 62905, held by Loch. Clindamycin Phosphate.

As of Nov 15, 2026, ANDA 62905 (Clindamycin Phosphate), held by Loch, was first approved by FDA on May 9, 1988, with 3 approved supplements and 0 published complete response letters.

First approved: May 9, 1988
Supplements approved: 3
Complete response letters: 0

Approvals and New Uses

The original application and every efficacy supplement, newest first; all 4 submissions below

Date	Submission	Status	Documents
May 9, 1988	Original application	Approved	None posted

Products

1 strengths and forms

Product	Active ingredient	Marketing
Clindamycin PhosphateEQ 150MG BASE/ML · injectable;injection	Clindamycin Phosphate	Discontinued

All 4 submissions, including labeling and manufacturing supplements


Jan 29, 1993	Supplement 7Labeling	Approved	None posted
Jul 13, 1989	Supplement 3Manufacturing	Approved	None posted
Sep 28, 1988	Supplement 1Manufacturing	Approved	None posted
May 9, 1988	Original application	Approved	None posted

Identifiers

Application: ANDA 62905
Drugs@FDA: Overview at FDA
Company: LOCH

Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters